(Q36587149)

15 August 2017

Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial (English)

1 reference

randomized controlled trial

15 August 2017

1 reference

11

Giovanni Meola

1 reference

15 August 2017

15

Michael G Hanna

1 reference

15 August 2017

Jeffrey M Statland

1

1 reference

15 August 2017

Brian N Bundy

2

1 reference

15 August 2017

Yunxia Wang

3

1 reference

15 August 2017

Dipa Raja Rayan

4

1 reference

15 August 2017

Jaya R Trivedi

5

1 reference

15 August 2017

Valeria A Sansone

6

1 reference

15 August 2017

Mohammad K Salajegheh

7

1 reference

15 August 2017

Shannon L Venance

8

1 reference

15 August 2017

Emma Ciafaloni

9

1 reference

15 August 2017

Emma Matthews

10

1 reference

15 August 2017

Laura Herbelin

12

1 reference

15 August 2017

Robert C Griggs

13

1 reference

15 August 2017

Richard J Barohn

14

1 reference

15 August 2017

Consortium for Clinical Investigation of Neurologic Channelopathies

16

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

The Journal of the American Medical Association

15 August 2017

1 reference

15 August 2017

308

1 reference

15 August 2017

13

1 reference

15 August 2017

1357-1365

1 reference

An interactive voice response diary for patients with non-dystrophic myotonia

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL).

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Drug treatment for myotonia

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

9 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

9 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Methods for assessing responsiveness: a critical review and recommendations

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Population frequencies of inherited neuromuscular diseases—A world survey

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Mexiletine block of wild‐type and inactivation‐deficient human skeletal muscle hNav1.4 Na+ channels

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Gating of myotonic Na channel mutants defines the response to mexiletine and a potent derivative

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

AAEE minimonograph #27: differential diagnosis of myotonic syndromes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Paramyotonia congenita: successful treatment with tocainide. Clinical and electrophysiologic findings in seven patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Cardiac conduction in myotonic dystrophy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

The treatment of myotonia: a controlled clinical trial.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Effect sizes for interpreting changes in health status.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564227

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)

20 September 2018

1 reference

12 December 2020

The crossover experiment for clinical trials

1 reference

12 December 2020

Carryover and the two-period crossover clinical trial

1 reference

12 December 2020

Treatment of myotonia with antiarrhythmic drugs

1 reference

12 December 2020

Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy

1 reference

12 December 2020

Electromyography guides toward subgroups of mutations in muscle channelopathies.

1 reference

12 December 2020

THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS

1 reference

12 December 2020

Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.2012.12607

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23032552

1 reference